 | Beam Therapeutics Inc. | |||
| NMS : BEAM || Location: United States | ||||
$24.310.0 (0.0%) |
1.71 M | 24.05 - 24.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 13.451 M |
| March 15, 2024 | 14.320 M |
| Feb. 29, 2024 | 13.108 M |
| Feb. 15, 2024 | 13.434 M |
| Jan. 31, 2024 | 13.389 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.03 | 1.73 | 267.72% |
| 09/30/2023 | -1.39 | -1.22 | 12.16% |
| 06/30/2023 | -1.45 | -1.08 | 25.68% |
| 03/31/2023 | -1.37 | -1.33 | 2.86% |
| 12/31/2022 | -1.35 | -0.54 | 60.13% |
BEAM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 81.658M | Shares Float | 73.326M |
| Short Float | 13.451M | Market Cap | 1985.11M |
| Institution ownership | 89.58% | Insider ownership | 1.840% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -1.72 | Forward EPS | -5.07 |